CHERYL KATAVICH: Open Payments
NPI 1295089266 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 20 payments from 10 companies in 2025. Trend: 2023 $63 · 2024 $312 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $83 |
| Amgen Inc. | 4 | $70 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| Ascendis Pharma Endocrinology Inc | 2 | $50 |
| Neurocrine BioSciences, Inc. | 1 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Dexcom, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
Products named: Korlym, Yorvipath, RECORLEV, CRENESSITY, EVENITY, MOUNJARO, Dexcom G6 Transmitter, Ozempic.
Industry payments across OH — which companies pay providers there.
